OptiNose, Inc.
1020 Stony Hill Road, Suite 300
Yardley, Pennsylvania 19067
August 23, 2021
VIA EDGAR
Office of Life Sciences
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
Attn: Gary Guttenberg
Re: OptiNose, Inc.
Registration Statement on Form S-3
Filed August 11, 2021
File No. 333-258707
Request for Acceleration of Effective Date
Dear Mr. Guttenberg:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, OptiNose, Inc. hereby requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form S-3 (the “Registration Statement”), and declare the Registration Statement effective as of 4:00 p.m., Eastern Daylight Time, on August 31, 2021, or as soon thereafter as possible.
Please feel free to direct any questions or comments concerning this request to Stephen Nicolai of Hogan Lovells US LLP at (267) 675-4642.
| Very truly yours, | ||
| OptiNose, Inc. | ||
| /s/ Keith A. Goldan | ||||||||
| By: | Keith A. Goldan | |||||||
| Title: | Chief Executive Officer | |||||||